Progressive Proximal-to-Distal Reduction in Expression of the Tight Junction Complex in Colonic Epithelium of Virally-Suppressed HIV+ Individuals

PLoS Pathogens

Volumn 10, Issue 6, 2014, Pages

  Chung, Charlotte Y ^a   Alden, Stephanie L ^a   Funderburg, Nicholas T ^b   Fu, Pingfu ^a   Levine, Alan D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; CD14 ANTIGEN; CLAUDIN 2; CLAUDIN 4; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; OCCLUDIN; PROTEIN ZO1; RNA DIRECTED DNA POLYMERASE INHIBITOR; UVOMORULIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TIGHT JUNCTION PROTEIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLON MUCOSA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENSITOMETRY; DESCENDING COLON; DOWN REGULATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION; TRANSCRIPTION REGULATION; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; ASCENDING COLON; COHORT ANALYSIS; COLON; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; HIV INFECTIONS; ILEUM; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; OHIO; PATHOLOGY; PERMEABILITY; TRANSVERSE COLON; UNIVERSITY HOSPITAL; VIROLOGY;

ACADEMIC MEDICAL CENTERS; ANTI-HIV AGENTS; COHORT STUDIES; COLON; COLON, ASCENDING; COLON, DESCENDING; COLON, TRANSVERSE; DOWN-REGULATION; FEMALE; HIV INFECTIONS; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OHIO; ORGAN SPECIFICITY; PERMEABILITY; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS;

EID: 84903473239     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004198     Document Type: Article

References (81)

1. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, et al. (2000) T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95: 249-255.
2. Lawn SD, Butera ST, Folks TM, (2001) Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin Microbiol Rev 14: 753-777 doi:10.1128/CMR.14.4.753-777.2001.
3. De Boer RJ, Mohri H, Ho DD, Perelson AS, (2003) Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J Immunol 170: 2479-2487.
4. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870 doi:10.1086/314660.
5. Deeks SG, (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947 doi:10.1182/blood-2003-09-3333.
6. Longenecker CT, Funderburg NT, Jiang Y, Debanne S, Storer N, et al. (2013) Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med 14: 385-390 doi:10.1111/hiv.12013.
7. Ross AC, Rizk N, O'Riordan MA, Dogra V, Bejjani El D, et al. (2009) Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy. Clin Infect Dis 49: 1119-1127 doi:10.1086/605578.
8. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA, (2011) Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 214: 468-473 doi:10.1016/j.atherosclerosis.2010.11.013.
9. French AL, Evans CT, Agniel DM, Cohen MH, Peters M, et al. (2013) Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis 208: 679-689 doi:10.1093/infdis/jit225.
10. Marchetti G, Nasta P, Bai F, Gatti F, Bellistrì GM, et al. (2012) Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients. PLoS ONE 7: e32028 doi:10.1371/journal.pone.0032028.s003.
11. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, et al. (2008) Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C. Gastroenterology 135: 226-233 doi:10.1053/j.gastro.2008.03.022.
12. Ancuta P, Kamat A, Kunstman KJ, Kim E-Y, Autissier P, et al. (2008) Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients. PLoS ONE 3: e2516 doi:10.1371/journal.pone.0002516.t003.
13. Deeks SG, Phillips AN, (2009) HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338: a3172-a3172 doi:10.1136/bmj.a3172.
14. Lohse N, Hansen A-BE, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95.
15. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371 doi:10.1038/nm1511.
16. Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, et al. (2009) Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection. J Infect Dis 199: 1177-1185 doi:10.1086/597476.
17. Baroncelli S, Galluzzo CM, Pirillo MF, Mancini MG, Weimer LE, et al. (2009) Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA. J Clin Virol 46: 367-370 doi:10.1016/j.jcv.2009.09.011.
18. Brenchley JM, Price DA, Douek DC, (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7: 235-239 doi:10.1038/ni1316.
19. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, et al. (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6: 205-214.
20. Funderburg NT, Stubblefield Park SR, Sung HC, Hardy G, Clagett B, et al. (2013) Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 140: 87-97 doi:10.1111/imm.12114.
21. Schietroma M, Carlei F, Cappelli S, Amicucci G, (2006) Intestinal Permeability and Systemic Endotoxemia After Laparotomic or Laparoscopic Cholecystectomy. Ann Surg 243: 359-363 doi:10.1097/01.sla.0000201455.89037.f6.
22. Schietroma M, Carlei F, Cappelli S, Pescosolido A, Lygidakis NJ, et al. (2007) Effects of cholecystectomy (laparoscopic versus open) on PMN-elastase. Hepatogastroenterology 54: 342-345.
23. Cooke KR, Olkiewicz K, Erickson N, Ferrara JLM, (2002) The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 8: 441-448 doi:10.1179/096805102125001046.
24. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, et al. (1997) Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213.
25. Klatt NR, Harris LD, Vinton CL, Sung H, Briant JA, et al. (2010) Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol 3: 387-398 doi:10.1038/mi.2010.14.
26. Mowat AM, Viney JL, (1997) The anatomical basis of intestinal immunity. Immunol Rev 156: 145-166.
27. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759 doi:10.1084/jem.20040874.
28. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77: 11708-11717.
29. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, et al. (1995) Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 37: 524-529.
30. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, et al. (2008) Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 1: 279-288 doi:10.1038/mi.2008.14.
31. Kim CJ, Nazli A, Rojas OL, Chege D, Alidina Z, et al. (2012) A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol pp. 1-11 doi:10.1038/mi.2012.72.
32. Ciccone EJ, Read SW, Mannon PJ, Yao MD, Hodge JN, et al. (2010) Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol 3: 172-181 doi:10.1038/mi.2009.129.
33. Epple H-J, Allers K, Tröger H, Kühl A, Erben U, et al. (2010) Acute HIV Infection Induces Mucosal Infiltration With CD4+ and CD8+ T Cells, Epithelial Apoptosis, and a Mucosal Barrier Defect. Gastroenterology 139: 1289-1300.e2 doi:10.1053/j.gastro.2010.06.065.
34. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, et al. (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538-545 doi:10.1128/JVI.01449-07.
35. George MD, Sankaran S, Reay E, Gelli AC, Dandekar S, (2003) High-throughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. Virology 312: 84-94.
36. Brenchley JM, Douek DC, (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1: 23-30 doi:10.1038/mi.2007.1.
37. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, et al. (1995) Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 37: 623-629.
38. Obinna FC, Cook G, Beale T, Dave S, Cunningham D, et al. (1995) Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS 9: 1009-1016.
39. Stockmann M, Schmitz H, Fromm M, Schmidt W, Pauli G, et al. (2000) Mechanisms of epithelial barrier impairment in HIV infection. Ann N Y Acad Sci 915: 293-303.
40. Stubblefield Park S, Sung H, Funderburg N, Meddings J, Levine A, (2012) Increased small intestinal and colonic permeability, and loss of villus tip surface area, correlates with microbial translocation and immune activation in HIV. J Immunol 188: 71.5.
41. Estes JD, Harris LD, Klatt NR, Tabb B, Pittaluga S, et al. (2010) Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections. PLoS Pathog 6: e1001052 doi:10.1371/journal.ppat.1001052.t001.
42. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J, (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19 doi:10.1186/gb-2007-8-2-r19.
43. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
44. Arrieta MC, (2006) Alterations in intestinal permeability. Gut 55: 1512-1520 doi:10.1136/gut.2005.085373.
45. Turner JR, (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809 doi:10.1038/nri2653.
46. Schulzke J-D, Günzel D, John LJ, Fromm M, (2012) Perspectives on tight junction research. Ann N Y Acad Sci 1257: 1-19 doi:10.1111/j.1749-6632.2012.06485.x.
47. Amasheh S, Milatz S, Krug SM, Markov AG, Günzel D, et al. (2009) Tight Junction Proteins as Channel Formers and Barrier Builders. Ann N Y Acad Sci 1165: 211-219 doi:10.1111/j.1749-6632.2009.04439.x.
48. Owens DW, Lane EB, (2004) Keratin mutations and intestinal pathology. J Pathol 204: 377-385 doi:10.1002/path.1646.
49. Gallo RL, Hooper LV, (2012) Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12: 503-516 doi:10.1038/nri3228.
50. Meng W, Takeichi M, (2009) Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 1: a002899-a002899 doi:10.1101/cshperspect.a002899.
51. Deeks SG, Tracy R, Douek DC, (2013) Systemic Effects of Inflammation on Health during Chronic HIV Infection. Immunity 39: 633-645 doi:10.1016/j.immuni.2013.10.001.
52. Marchetti G, Tincati C, Silvestri G, (2013) Microbial Translocation in the Pathogenesis of HIV Infection and AIDS. Clin Microbiol Rev 26: 2-18 doi:10.1128/CMR.00050-12.
53. Epple H-J, Schneider T, Troeger H, Kunkel D, Allers K, et al. (2009) Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58: 220-227 doi:10.1136/gut.2008.150425.
54. Smith AJ, Schacker TW, Reilly CS, Haase AT, (2010) A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. J Acquir Immune Defic Syndr 55: 306-315 doi:10.1097/QAI.0b013e3181ecfeca.
55. Veazey RS, (1998) Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection. Science 280: 427-431 doi:10.1126/science.280.5362.427.
56. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, et al. (2008) Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835 doi:10.1182/blood-2008-05-159301.
57. Olsson J, Poles M, Spetz AL, Elliott J, Hultin L, et al. (2000) Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 182: 1625-1635 doi:10.1086/317625.
58. McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, et al. (2004) Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 37: 1228-1236.
59. Hofer U, Schlaepfer E, Baenziger S, Nischang M, Regenass S, et al. (2010) Inadequate Clearance of Translocated Bacterial Products in HIV-Infected Humanized Mice. PLoS Pathog 6: e1000867 doi:10.1371/journal.ppat.1000867.s004.
60. Li Q, Estes JD, Duan L, Jessurun J, Pambuccian S, et al. (2008) Simian Immunodeficiency Virus-Induced Intestinal Cell Apoptosis Is the Underlying Mechanism of the Regenerative Enteropathy of Early Infection. J Infect Dis 197: 420-429 doi:10.1086/525046.
61. Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, et al. (2005) Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci USA 102: 9860-9865 doi:10.1073/pnas.0503463102.
62. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, et al. (2010) Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation. PLoS Pathog 6: e1000852 doi:10.1371/journal.ppat.1000852.t001.
63. Batman PA, Miller AR, Forster SM, Harris JR, Pinching AJ, et al. (1989) Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. Journal of Clinical Pathology 42: 275-281 doi:10.1136/jcp.42.3.275.
64. Sandler NG, Wand H, Roque A, Law M, Nason MC, et al. (2011) Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection. J Infect Dis 203: 780-790 doi:10.1093/infdis/jiq118.
65. Mavigner M, Cazabat M, Dubois M, L'Faqihi F-E, Requena M, et al. (2011) Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 122: 62-69 doi:10.1172/JCI59011DS1.
66. Hunt PW, (2012) HIV and Inflammation: Mechanisms and Consequences. Curr HIV/AIDS Rep 9: 139-147 doi:10.1007/s11904-012-0118-8.
67. Pelsers MMAL, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, et al. (2003) Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clinical Biochemistry 36: 529-535 doi:10.1016/S0009-9120(03)00096-1.
68. LaPointe LC, Dunne R, Brown GS, Worthley DL, Molloy PL, et al. (2008) Map of differential transcript expression in the normal human large intestine. Physiological Genomics 33: 50-64 doi:10.1152/physiolgenomics.00185.2006.
69. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, et al. (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12: 755-762.
70. Iacopetta B, (2002) Are there two sides to colorectal cancer? Int J Cancer 101: 403-408 doi:10.1002/ijc.10635.
71. Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, et al. (2011) Colon carcinoma. European Journal of Surgical Oncology 37: 134-139 doi:10.1016/j.ejso.2010.12.004.
72. Stearns JC, Lynch MDJ, Senadheera DB, Tenenbaum HC, Goldberg MB, et al. (2011) Bacterial biogeography of the human digestive tract. Sci Rep 1doi:10.1038/srep00170.
73. Li X, LeBlanc J, Truong A, Vuthoori R, Chen SS, et al. (2011) A Metaproteomic Approach to Study Human-Microbial Ecosystems at the Mucosal Luminal Interface. PLoS ONE 6: e26542 doi:10.1371/journal.pone.0026542.t001.
74. Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, et al. (2012) Colorectal cancer: a tale of two sides or a continuum? Gut 61: 794-797 doi:10.1136/gutjnl-2012-302014.
75. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, et al. (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61: 847-854 doi:10.1136/gutjnl-2011-300865.
76. Brenchley JM, Douek DC, (2012) Microbial Translocation Across the GI Tract. Annu Rev Immunol 30: 149-173 doi:10.1146/annurev-immunol-020711-075001.
77. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, et al. (2012) Pathogenic Simian Immunodeficiency Virus Infection Is Associatedwith Expansion of the Enteric Virome. Cell 151: 253-266 doi:10.1016/j.cell.2012.09.024.
78. Lozupone CA, Li M, Campbell TB, Flores SC, Linderman D, et al. (2013) Alterations in the Gut Microbiota Associated with HIV-1 Infection. Cell Host and Microbe 14: 329-339 doi:10.1016/j.chom.2013.08.006.
79. Eckburg PB, (2005) Diversity of the Human Intestinal Microbial Flora. Science 308: 1635-1638 doi:10.1126/science.1110591.
80. Ellis CL, Ma Z-M, Mann SK, Li C-S, Wu J, et al. (2011) Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 57: 363-370 doi:10.1097/QAI.0b013e31821a603c.
81. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, et al. (2013) Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. Sci Transl Med 5: 193ra91-193ra91 doi:10.1126/scitranslmed.3006438.